Targeting Overactive Mitochondrial Pathways Kills Aggressive Melanoma Cells Using Existing Drugs

Publication date: Jul 08, 2025

The study found that these melanoma cells overactivate two critical processes within mitochondria, which are responsible for generating energy in cells. This approach leverages existing pharmaceutical options to interfere with the energy production mechanisms that sustain aggressive cancer growth. The study provides insight into potential therapeutic strategies for treating advanced melanoma by focusing on cellular energy pathways. Newsflash | Powered by GeneOnline AISource: GO-AI-ne1Date: June 23, 2025Author Mark Chiang Researchers observed that disrupting these overactive mitochondrial functions with readily available medications led to significant cell death in laboratory settings.

Concepts Keywords
Cancer Aggressive
Deadliest Cells
Driving Chiang
June Drugs
Ne1date Drugsby
Energy
Existing
Kills
Mark
Melanoma
Mitochondria
Mitochondrial
Overactive
Pathways
Targeting

Semantics

Type Source Name
disease MESH Melanoma
pathway KEGG Melanoma
disease MESH skin cancer
disease MESH cancer

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *